e-learning
resources
Berlin 2008
Monday, 06.10.2008
New frontiers in noninvasive assessment of the lungs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy
G. de Laurentiis, D. Paris, D. Melck, M. Maniscalco, S. Marsico, G. Corso, A. Motta, M. Sofia (Naples, Pozzuoli, Naples, Foggia, Italy)
Source:
Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Session:
New frontiers in noninvasive assessment of the lungs
Session type:
Oral Presentation
Number:
1563
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. de Laurentiis, D. Paris, D. Melck, M. Maniscalco, S. Marsico, G. Corso, A. Motta, M. Sofia (Naples, Pozzuoli, Naples, Foggia, Italy). Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 2008; 32: Suppl. 52, 1563
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Matteo Sofia - 09.05.2009 04:37
A very interesting new methodological approach to study the metabolism of lower airways.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
A metabonomic approach to prognostic evaluation of ALI by high-resolution nuclear magnetic resonance (HR NMR) spectroscopy
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Methodological aspects of nuclear magnetic resonance spectroscopy of exhaled breath condensate
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy
Source: Eur Respir J 2008; 32: 1175-1183
Year: 2008
Nuclear magnetic resonance and mass spectrometry analysis of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009
Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma
Source: Eur Respir J 2012; 39: 500-502
Year: 2012
Lung perfusion measured using magnetic resonance imaging
Source: Annual Congress 2012 - Functional pulmonary imaging for COPD phenotyping
Year: 2012
Nuclear magnetic resonance-based metabolomics in respiratory medicine
Source: Eur Respir J, 52 (4) 1801107; 10.1183/13993003.01107-2018
Year: 2018
Regional measures of 3D lung mechanics using magnetic resonance imaging
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Evidence for continuous alveolisation during childhood, using 3He magnetic resonance
Source: Annual Congress 2009 - Exciting studies with old and new lung function tests
Year: 2009
129Xenon-enhanced magnetic resonance imaging to understand particle exhalation from the human lung
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Feasibility of spirometry-controlled chest magnetic resonance imaging (MRI) in children
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Hyperpolarised
129
Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019
Predicting multiple breath washout outcomes from hyperpolarised gas magnetic resonance imaging (MRI).
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Detection of NO in induced sputum by ESR (electron spin resonance) spectrometry
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept